BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

LFB Biotechnologies 

3, avenue des Tropiques

Les Ulis  Cedex  91958  France
Phone: Fax:


SEARCH JOBS








 Company News
TG Therapeutics, Inc. (MHA) Nabs $25 Million; Completes Licensing Agreement With LFB Biotechnologies for the Development of Ublituximab 3/2/2012 7:38:49 AM    More...
Acquisition of GTC Biotherapeutics (GTCB) by LFB Biotechnologies Completed 12/6/2010 11:17:16 AM    More...
Thallion Pharmaceuticals Inc. and LFB Biotechnologies Initiate Phase II SHIGATEC Trial 11/29/2010 9:51:57 AM    More...
French Biotech LFB Biotechnologies to Buy GTC Biotherapeutics (GTCB); GTC Agrees to go Private for $.30 Per Share 11/8/2010 8:03:05 AM    More...
LFB Biotechnologies Offers to Take GTC Biotherapeutics (GTCB) Private for $.28 Per Share for Total of $17 Million 10/19/2010 7:13:01 AM    More...
BAC B.V. Affinity Ligand Licensed for Clinical and Commercial Scale-up of LFB Biotechnologies' Recombinant Factor VIIa 4/13/2010 10:24:24 AM    More...
GTC Biotherapeutics (GTCB) Enters into Agreement to Receive $7 Million in Financing from LFB Biotechnologies 2/22/2010 6:26:41 AM    More...
Thallion Pharmaceuticals Inc. and LFB Biotechnologies Sign Definitive Agreement to Develop and Commercialize Treatment for E. Coli (STEC) Infection; Thallion Eligible to Receive up to 95 Million Euros 2/16/2010 8:51:25 AM    More...
Thallion Pharmaceuticals Inc. Announces Letter of Intent With LFB Biotechnologies to Develop and Commercialize Shigamabs(R) 12/18/2009 10:14:24 AM    More...
LFB Biotechnologies's Recombinant Anti-CD20 Monoclonal Antibody is Granted Orphan Drug Status in Europe for Chronic Lymphocytic Leukemia 11/25/2009 9:05:32 AM    More...
123

//-->